Dynamic42 interviewed by MDR
In the interview with MDR Thüringen, we answer many questions about our company, our vision and we reveal how we came up with the name “Dynamic42”. You can find the complete interview and the feature in the MDR Thüringen Journal here.
Read more News:
News
Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer
Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.
Read MoreNews
Press Release | Dynamic42 and research partners present three-organ system to reduce animal testing
Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.
Read MoreNews
Dynamic42 interviewed by the OTZ
We were interviewed by the Ostthüringer Zeitung on the subject of animal-free research.
Read More